| 2018 update of the EULAR recommendations for the management of Behçet's syndrome | Annals of the Rheumatic Diseases | 2018 | 277 |
| Cryoglobulinaemia | Nature Reviews Disease Primers | 2018 | 76 |
| Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases | International Journal of Molecular Sciences | 2018 | 72 |
| Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations | Rheumatology | 2018 | 57 |
| Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations | Journal of Autoimmunity | 2018 | 53 |
| Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes | Journal of Autoimmunity | 2018 | 50 |
| Nocebos in rheumatology: emerging concepts and their implications for clinical practice | Nature Reviews Rheumatology | 2018 | 47 |
| Systemic lupus erythematosus: state of the art on clinical practice guidelines | RMD Open | 2018 | 42 |
| Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study | Seminars in Arthritis and Rheumatism | 2018 | 39 |
| B-cell activating factor and related genetic variants in lupus related atherosclerosis | Journal of Autoimmunity | 2018 | 32 |
| Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment | Frontiers in Immunology | 2018 | 28 |
| Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis | Scandinavian Journal of Rheumatology | 2018 | 26 |
| Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort | Autoimmunity Reviews | 2018 | 23 |
| Adenosine-to-Inosine RNA Editing in Health and Disease | Antioxidants and Redox Signaling | 2018 | 21 |
| Antiphospholipid syndrome: state of the art on clinical practice guidelines | RMD Open | 2018 | 21 |
| Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study | Seminars in Arthritis and Rheumatism | 2018 | 17 |
| Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation | Journal of Autoimmunity | 2018 | 17 |
| TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients | Journal of Immunology Research | 2018 | 17 |
| High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients | Clinical and Experimental Rheumatology | 2018 | 17 |
| Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis | Clinical Immunology | 2018 | 16 |
| Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study | Arthritis Research and Therapy | 2018 | 16 |
| Update on assessment and management of primary cardiac involvement in systemic sclerosis. | Journal of Scleroderma and Related Disorders | 2018 | 15 |
| Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate | Autoimmunity Reviews | 2018 | 14 |
| Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease | Echocardiography | 2018 | 13 |
| Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity | Rheumatology | 2018 | 13 |
